Stack maps, corpus quarterlies, regulatory analysis, and N=1 lab data - synthesized from 5,734 podcast operators, 141,000 investor notes, and 17 years of family biomarker data. For founders, operators, and investors in the longevity vertical.
Compounded is a faceless analyst publication. There is no founder, no headshot, no LinkedIn - by design. The value here is not personality. It is the substrate: a 5,734-episode operator-podcast corpus, four years of buy-side deal notes, and one family’s 17-year biomarker record, read in parallel.
Anonymity buys independence. We cover the operators and processors who serve this market without owing any of them coverage in return. Every claim is sourced - FDA letter, podcast timestamp, SEC filing, scraped data point. If you want a name attached to a take, read someone else.
What you can expect: bi-weekly long-form, free, no tracking pixels, no sponsored placements in the body of the analysis. Not investment advice. Not medical advice.
Every claim in Compounded is traceable to a publicly verifiable source. FDA letters by URL, SEC filings by docket number, podcast claims by episode and timestamp, vendor relationships by press release or public client list, regulatory actions by docket. If we cannot link it, we do not publish it. Citation density is the audit trail.
Operators named in a piece are notified seventy-two hours before publish and offered right of reply. If they respond, we include their response. If they do not, we move on. Standard analyst-journalism practice, and the cheapest insurance against bad faith.
Corrections are public and fast. When we get something wrong, an updated version goes live within twenty-four hours with a dated note at the top of the piece, and a line in the next issue. Trust comes from visible self-correction, not from a perfect record nobody would believe anyway.
What we do not do: insider gossip, unverified rumors, deal-flow scoops, or attacks on operators in private. We are not a Twitter-thread account. We are an analyst publication, and the two are different products with different obligations.
What we openly admit: the corpus is not infallible, our analysis can be wrong, and every piece closes with a short list of the limits of our knowledge. If you spot an error, write to corrections@compounded.health. If you have material that would sharpen an upcoming piece, write to tips@compounded.health - encrypted contact available on request.
How operators are actually built. Vendors, high-risk processors, LegitScript posture, fulfillment partners, ad accounts, patient-data tooling - drawn from public sources and cross-referenced against the corpus.
Blood panels, Whoop traces, continuous glucose, sleep architecture - run on real protocols, anonymized per a published rule set. Honest about what moved and what didn’t.
What N podcast operators said about X this quarter. Drawn from a 5,734-episode FTS index plus 141k buy-side deal notes. Signal that nobody listens to all of, in one read.
FDA warning letters, state med-board moves, processor BRAM updates, VIRP timelines. What changed, who it hits first, and the second-order effects through the supply chain.
How today’s longevity market resembles historical analogs - dot-com infrastructure, early DTC, fintech rails ’14–’18. Pattern matching from inside the deal-flow corpus.
The flagship example. Vendor stack, high-risk processing arrangement, compliance posture, ad accounts that haven't been banned, pharmacy partner, patient-data tooling. The public-source map of an operator most of this audience has heard of.Source: competitive intel work + corpus cross-reference.
The economics, the regulatory pressure, and how state-by-state licensing is reshaping the model. What the next generation of physician-network infrastructure looks like, and which operators are building it. Pattern-matched to fintech rails ’16–’18.Source: operator interviews via corpus + the NoHo stack map.
FTS-indexed pull from the operator podcast corpus. Twelve operators, four hours of unique audio each. What they’re bullish on, what they’re quietly de-risking, the words they don’t use on stage.Source: youtube_corpus FTS index - 5,734 episodes.
One household. Five subjects. Lipids, ApoB, HOMA-IR, hsCRP, lp(a), Vitamin D, ferritin, hormones, thyroid. What moved with protocol, what moved with age, what was noise. Anonymized per the published rule set.Source: Health Agent personal data - anonymized.
Visa’s integrity program just changed posture on high-risk descriptors. Which clinic categories get reclassified, which processors are quietly repricing, and the 90-day window to restructure before chargebacks hit.Source: VIRP bulletin + Corepay / NMI source desk.
Every cash-pay longevity clinic sits on the same five-layer stack: high-risk processor, pharmacy partner, state-by-state telehealth wrapper, ad-account redundancy, and patient-data tooling. NoHo Labs is a useful first study because their version of the stack is public-source visible end to end. This issue walks the full assembly, layer by layer - every vendor, every trade-off, and what other operators are choosing differently.